1. Home
  2. ABCL vs WVE Comparison

ABCL vs WVE Comparison

Compare ABCL & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • WVE
  • Stock Information
  • Founded
  • ABCL 2012
  • WVE 2012
  • Country
  • ABCL Canada
  • WVE Singapore
  • Employees
  • ABCL N/A
  • WVE N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABCL Health Care
  • WVE Health Care
  • Exchange
  • ABCL Nasdaq
  • WVE Nasdaq
  • Market Cap
  • ABCL 1.1B
  • WVE 915.6M
  • IPO Year
  • ABCL 2020
  • WVE 2015
  • Fundamental
  • Price
  • ABCL $4.55
  • WVE $7.12
  • Analyst Decision
  • ABCL Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • ABCL 5
  • WVE 17
  • Target Price
  • ABCL $8.00
  • WVE $19.94
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • WVE 2.4M
  • Earning Date
  • ABCL 11-03-2025
  • WVE 11-11-2025
  • Dividend Yield
  • ABCL N/A
  • WVE N/A
  • EPS Growth
  • ABCL N/A
  • WVE N/A
  • EPS
  • ABCL N/A
  • WVE N/A
  • Revenue
  • ABCL $32,875,999.00
  • WVE $93,946,000.00
  • Revenue This Year
  • ABCL $15.60
  • WVE N/A
  • Revenue Next Year
  • ABCL $65.70
  • WVE $10.02
  • P/E Ratio
  • ABCL N/A
  • WVE N/A
  • Revenue Growth
  • ABCL N/A
  • WVE N/A
  • 52 Week Low
  • ABCL $1.89
  • WVE $5.28
  • 52 Week High
  • ABCL $5.82
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 57.55
  • WVE 30.87
  • Support Level
  • ABCL $4.09
  • WVE $6.97
  • Resistance Level
  • ABCL $4.28
  • WVE $7.76
  • Average True Range (ATR)
  • ABCL 0.24
  • WVE 0.50
  • MACD
  • ABCL 0.03
  • WVE -0.32
  • Stochastic Oscillator
  • ABCL 82.76
  • WVE 4.17

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: